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Color carboxymethylation of cysteine residues with a new chromophoric reagent dimethylaminoazoben- 
zene iodoacetamide, was applied to the micro-sequence analysis of hirudin, a thrombin specific inhibitor. 
Six cysteine residues of the reduced hirudin were detected as colored phenylthiohydantoin derivative and 
3 tryptic peptides of hirudin (all containing cysteines) were isolated as colored peptide. The complete 
hirudin sequence, including 6 uncertain positions left in the previous report [Petersen T.E. et al. (1976) 
in: Protides of the Biological Fluids; 23rd Colloquium, pp. 145, Pergamon Press, London] was 
established. 
Hirudin Tyrosine sulfate 
1. INTRODUCTION 
Hirudin is a potent thrombin-specific inhibitor 
[1,2] isolated from the salivary glands of the leech 
Hirudo medicinalis. It forms a tight complex with 
a-thrombin with an equilibrium dissociation cons- 
tant of as low as 0.82x 10-r’ mol/l [3]. This high 
binding affinity had led to the speculation that in- 
teraction of hirudin with cu-thrombin must com- 
prise multiple binding sites [4,5]. In an attempt to 
elucidate the molecular mechanism of thrombin in- 
hibition by hirudin, the complete amino acid se- 
quence has to be determined. 
We describe here the complete sequencing of 
hirudin by applying a newly developed technique 
[6]. (a) Cysteine was identified as a colored 
Abbreviations: DABIA, 4-dimethylaminobenzene 
4’-iodoacetamide; DABITC, dimethylaminoazobenzene 
isothiocyanate; DABS-Cl, dimethylaminoazobenzene 
sulfonyl chloride; HPLC, high-performance liquid chro- 
matography; PTH, phenylthiohydantoin 
Color carboxymethylation 
derivative by specific labelling with DABIA. The 
colored cysteine derivatives are directly visible at 
the 100 pmol level in the sequenator fractor collec- 
tor (e.g. residue 39 in fig. 1) and can be analysed by 
HPLC at the 5-10 pmol level. (b) Peptides were 
isolated as colored peptides by labelling at the cys- 
teine residue. Since every tryptic peptide of hirudin 
contains at least one cysteine, all tryptic peptides 
were isolated in colored form without supplemen- 
ting an additional derivatization method [7,8]. 
This technical approach has demonstrated that the 
sequence of a small cysteine-containing protein can 
be determined in an efficient and sensitive way. 
2. MATERIALS AND METHODS 
2.1. Materials 
Hirudin was isolated from the whole body of 
leeches as in [l] with some modifications (to be 
published) and its purity was ascertained by 
SDS-gel electrophoresis and N-terminal analysis 
[9]. DABIA was synthesized as in [6]. DABS-Cl 
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and DABITC were obtained from Fluka. All other 
chemicals and solvents used in both HPLC analy- 
sis and sequenator un were commercial analytical 
grade from Merck. 
2.2. Methodologies used in protein chemistry 
Protein was reduced [lo] and color carbox- 
ymethylated with a 2-3 molar excess of DABIA as 
in [6]. Excess DABIA was removed by gel filtra- 
tion (G-25 superfine, eluted with 50% acetic acid). 
Amino terminal of polypeptide was determined by 
the DABITC method [9]. Amino acid composition 
and C-terminal sequence were analysed by the 
DABS-Cl method [ 11,121 and carboxypeptidase Y
[13]. Automatic sequencing [ 141 was performed on 
a modified Beckman 890C sequenator [15,16] and 
the released phenylthiohydantoins were analyzed 
by JPLC on a Zorbax-CN column [16]. PTH 
derivative of DABIA carboxymethylated cysteine 
was also quantitatively analysed by HPLC [6]. 
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Fig. 1. Yields of PTH derivatives of amino acids from a 
sequenator un performed with 3.5 nmol hirudin. Both 
Ser and Thr were positively identified through their 
characteristic by-products [15] but were not quantita- 
tively analysed. Phenylthiohydantoins of color-labelled 
cysteine were quantitatively analysed at 436 nm filled 
columns). The first 39 amino acids were identified but 
uncertain gaps were left at positions 33, 34 and 38. 
Those gaps were finally assigned by sequencing the 
3. RESULTS AND DISCUSSION tryptic peptides. 
3.1. Amino acid sequencing of hirudin 
Amino acid composition analysis by both stan- 
dard analyser [17] and the DABS-Cl method 
[ll, 121 shows that hirudin contains 3 molecules of 
lysine and 6 molecules of cysteine per molecule of 
hirudin. No arginine was detected (not shown). 
once more confirmed in these tryptic peptides. 
Native hirudin (60 nmol) was reduced with 
dithiothreitol [lo] and sulfhydryl groups were 
labelled with DABIA [6]. Two samples (7 and 3.5 
nmol) of the colored hirudin were subjected to 
automatic Edman degradation [14] and in both 
runs, only the first 39 amino acids were deter- 
mined. Six cysteine residues were assigned at posi- 
tions 6, 14, 16,22, 28 and 39 directly through their 
visible purple-red color in the fraction collector 
tubes at the sequenator (fig.1). 
About 12 nmol colored hirudin was digested 
with trypsin and the colored tryptic peptides were 
isolated by HPLC and detected in the visible 
region (fig.2). They were recovered (yield 2.5-5 
nmol) and sequenced by automatic Edman degra- 
dation, all through their C-terminal ends. From 
the PTH derivative analysis, residue 63 (from pep- 
tide in fraction 1 of fig.2) was found to be Tyr in- 
stead of Tyr-SO3H reported in [2]. Fractions 1, 3 
and 4 account for the complete sequence of hirudin 
and the positions of the 6 colored cysteines were 
The final stage of hirudin sequencing was C- 
terminal sequence analysis. One nmol carboxy- 
methylated hirudin was digested by carboxypep- 
tidase Y and released amino acids were analysed by 
the DABS-Cl method [11,12] (fig.3). The digestion 
drastically slowed down at residue 58 and although 
nearly equal amounts (mol) of Gln, leu, Pro, Ile 
and double (mol) of Glu were released after 20 min 
digestion, only 0.12 mol of Tyr was recovered. In- 
stead, there appeared an unknown acidic amino 
acid (fig.3). This result did not fit into the sequence 
obtained from tryptic peptide 1, as automatic se- 
quencing clearly indicated that position 63 was 
Tyr. It was soon realized that this unknown acidic 
amino acid was a Tyr derivative which can be 
readily converted to Tyr by mild acid hydrolysis. 
This Tyr derivative was identified as Tyr-O-sulfate 
through the following observations and experi- 
ments: (a) Its marked acidic lability is characteris- 
tic for an aryl sulfate [18]. (b) This acidic Tyr 
derivative is not Tyr-O-phosphate, since a stan- 
dard Tyr-O-phosphate (Sigma) is eluted immedia- 
tely after Glu. (c) This acidic Tyr derivative has the 
same elution time as synthetic Tyr-0-sulphate 
(synthesized as in [19]). The C-terminal sequence 
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Fig.2. Preparative isolation of hirudin-derived cysteine- 
containing peptides by HPLC. The DABJA labelled 
hirudin (12 nmol) was digested by trypsin in 150~1 of 0.1 
M ammonium bicarbonate at 37°C for 24 h. Fifty 
percent (75 ~1) of the sample (6 nmol) was loaded for 
each preparative isolation run. Recoveries were 20-40%. 
The peptides in fractions 1, 3 and 4 account for the 
complete sequence of hirudin and their corresponding 
positions in the hirudin sequence are indicated. NO 
sequence result was obtained from automatic sequencing 
of peptide in fraction 2. Chromatographical conditions 
were: solvent A, 0.01 M phosphate (pH 7.0), containing 
2% dimethylformamide; solvent B, acetonitrile; 
gradient, 20-75% B in 18 min; column, Merck RP-18 (5 
gm); column temperature, 22°C; Detector, 436 nm, 2.0 
absorption unit full scale. 
Table 1 
Time-course release of C-terminal amino acids from 
hirudin by carboxypeptidase Y digestion” 
Period of - Be - Pro - Glub - Glub - TyrC - Leu - Gln 
digestion 
(min) 
3 0.12 0.19 (0.24) 0.50 0.61 0.95 
10 0.42 0.54 (0.66) 0.87 0.91 0.97 
20 0.73 0.89 (1.08) 0.99 0.98’ 0.96 
a Aliquots of 10 pmol were used for amino acid analysis. 
The listed values represent mol amino acid/m01 
protein 
b The listed values represent only 50% of the total Glu 
yield 
’ The yield of Tyr-O-sulfate was corrected for its 12% 
desulfated derivative 
determined by digestion with carboxypeptidase Y
fits precisely with the sequence obtained from Ed- 
man degradation (table 1) and the complete 
hirudin sequence is shown in fig.4. 
3.2. Color carboxymethylation 
Cysteine residues of polypeptides have to be 
chemically modified prior to sequence determina- 
tion. There are a number of chemical methods 
availabie for this purpose 120,211, including the 
0 15 30 
Fig.3. Analysis of amino acids (by DABS-Cl method) released from hirudin after 20 min of carboxypeptidase Y
digestion. Two hundred pmol c~boxymethylated hirudin were digested with 0.2 pg carboxypeptidase Y in 10 ,ul 
phosphate buffer (pH 5.4) at room temperature for 20 min. The sample was freeze-dried, derivatized with DABS-Cl 
and 5% of the total sample (10 pmol) was applied for amino acid analysis. DABS-amino acids are symbolized by the 
one letter code of their corresponding amino acid. Y *, DABS-Tyr-O-sulfate. By-products originating from the reagent 
are marked by asterisk. The appearance of Gly was not expected from the C-terminal sequence of hirudin and is believed 
to be introduced into the sample during the carboxymethylation. Chromatographical conditions were: solvent A, 0.012 
M phosphate (pH 6.5), solvent B, acetonitrile containing 4% dimethylformamide; gradient, 12-37% B/O-22 min, 37- 
60% B/22-35 min, kept at 60% B at 35-40 min then 60-12% B/40-45 min; column, Merck RP-18 (5 pm); column 
182 
temperature, SO’C; detector, 436 nm, 0.01 absorption until full scale. 
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Fig.4. The complete amino acid sequence of native hirudin. By trypsin digestion, the lysyl bonds in positions 27 and 
36 were cleaved whereas the lysyl bond in position 47 was resistant. 
most popular techniques, such as carboxymethyla- 
tion [22] and performic acid oxidation [23]. How- 
ever, analysis of chemically modified cysteine is, in 
general, more difficult than that of common amino 
acids. For instance, PTH-cysteic acid is not extract- 
able by organic solvent in the liquid phase Edman 
degradation and PTH-carboxymethyl cysteine has 
the tendency of breaking down like the serine 
derivative. To circumvent this problem in micro- 
sequencing, radioactive carboxymethylation be- 
came one of the most commonly used approaches. 
The color carboxymethylation employing 
DABIA has advantages over the radioactive car- 
boxymethylation. (a) DABIA labelled cysteine and 
peptide derivatives [6] have a molar extinction 
coefficient of 30000. These colored amino acid 
and peptide derivatives are separated by HPLC 
and detected in the visible region with the signal: 
baseline noise ratio of at least 3000 nmol-‘, 
whereas radioactive carboxymethylation employ- 
ing standard conditions [24] gave about 150-200 
nmol-’ of signal: background noise ratio (assum- 
ing the background radioactivity is 20 cpm). (b) 
DABIA-labelled cysteine is much more hydropho- 
bic than iodoacetic acid-labelled cysteine or cysteic 
acid, assuring quantitative extraction of cysteine 
derivative from the spinning cup during micro- 
sequence analysis. 
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